Zomedica (9/13/2021)
In this webinar, case scenarios outlining the most common questions asked when approaching a patient with suspected hyperadrenocorticism will be presented.
What You'll Learn
- Become familiar with common issues that arise when presented with a patient with suspected hyperadrenocorticism
- Determine which patients will require additional diagnostics and which patients will require treatment
- Become familiar with the pros and cons of adrenal/pituitary testing
Company Description
Zomedica (NYSE American: ZOM) is a veterinary health company dedicated to providing clinical veterinarians with the innovative diagnostics and medical devices they need to better serve the dogs and cats in their care. The company’s mission is to advance animal health and practitioner success by focusing on the development of products and services that allow veterinarians to increase productivity and grow revenue while fostering positive health outcomes. Based in Ann Arbor, MI, the company recently launched its inaugural product, TRUFORMA®, an in-clinic biosensor platform of highly sensitive, species-specific assays offering lab quality results for the accurate diagnosis of thyroid and adrenal disorders. For more information, visit www.zomedica.com.
In this webinar, case scenarios outlining the most common questions asked when approaching a patient with suspected hyperadrenocorticism will be presented.
What You'll Learn
- Become familiar with common issues that arise when presented with a patient with suspected hyperadrenocorticism
- Determine which patients will require additional diagnostics and which patients will require treatment
- Become familiar with the pros and cons of adrenal/pituitary testing
Company Description
Zomedica (NYSE American: ZOM) is a veterinary health company dedicated to providing clinical veterinarians with the innovative diagnostics and medical devices they need to better serve the dogs and cats in their care. The company’s mission is to advance animal health and practitioner success by focusing on the development of products and services that allow veterinarians to increase productivity and grow revenue while fostering positive health outcomes. Based in Ann Arbor, MI, the company recently launched its inaugural product, TRUFORMA®, an in-clinic biosensor platform of highly sensitive, species-specific assays offering lab quality results for the accurate diagnosis of thyroid and adrenal disorders. For more information, visit www.zomedica.com.